Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Holdings, Q3 2026

Largest first. Common shares only.

Latest 13F holdings
#The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here.Filing
1BMY
Bristol-Myers Squibb Company
612,962$38.2M7.9%-15.6%13F ↗
2PFE
Pfizer, Inc.
1.27M$36.1M7.5%+26.2%13F ↗
3MDT
Medtronic plc.
381,245$32.9M6.8%+8.2%13F ↗
4MRK
Merck & Company, Inc.
193,044$28.1M5.8%-11.0%13F ↗
5INCY
Incyte Corporation
155,100$18.8M3.9%-9.2%13F ↗
6BMRN
BioMarin Pharmaceutical Inc.
293,293$17.6M3.6%-0.6%13F ↗
7CVS
CVS Health Corporation
196,574$16.8M3.5%+26.5%13F ↗
8GEHC
GE HealthCare Technologies Inc.
256,906$16.8M3.5%+23.6%13F ↗
9ELV
Elevance Health, Inc.
40,229$15.6M3.2%-9.6%13F ↗
10BIIB
Biogen Inc.
66,646$15.1M3.1%+23.0%13F ↗
11IONS
Ionis Pharmaceuticals, Inc.
330,037$14.7M3.0%+74.2%13F ↗
12BRKR
Bruker Corporation
217,352$14.1M2.9%+42.7%13F ↗
13DHR
Danaher Corporation
63,381$14.0M2.9%New13F ↗
14ABT
Abbott Laboratories
141,741$14.0M2.9%-3.9%13F ↗
15BDX
Becton, Dickinson and Company
75,630$13.5M2.8%-18.8%13F ↗
16BSX
Boston Scientific Corporation
308,128$13.4M2.8%+154%13F ↗
17BIO
Bio-Rad Laboratories, Inc. Class A
33,350$12.6M2.6%Unchanged13F ↗
18ZBH
Zimmer Biomet Holdings, Inc.
131,484$11.7M2.4%-7.6%13F ↗
19IQV
IQVIA Holdings, Inc.
42,283$11.4M2.3%-45.8%13F ↗
20REGN
Regeneron Pharmaceuticals, Inc.
14,184$10.8M2.2%-10.1%13F ↗
21QGEN
Qiagen N.V.
231,170$10.1M2.1%-19.6%13F ↗
22LH
Labcorp Holdings Inc.
31,019$9.6M2.0%+19.2%13F ↗
23AVTR
Avantor, Inc.
606,088$9.1M1.9%-33.1%13F ↗
24CAH
Cardinal Health, Inc.
40,301$9.0M1.8%-1.0%13F ↗
25CNC
Centene Corporation
142,405$8.8M1.8%-12.3%13F ↗
26UNH
UnitedHealth Group Incorporated
20,000$7.3M1.5%New13F ↗
27AZN
AstraZeneca PLC
45,049$7.3M1.5%New13F ↗
28PTCT
PTC Therapeutics, Inc.
112,000$7.3M1.5%+12.0%13F ↗
29IOVA
Iovance Biotherapeutics, Inc.
388,466$5.8M1.2%-59.9%13F ↗
30EW
Edwards Lifesciences Corporation
60,402$5.2M1.1%Unchanged13F ↗
31KURA
Kura Oncology, Inc.
433,012$4.6M1.0%Unchanged13F ↗
32SNDX
Syndax Pharmaceuticals, Inc.
241,739$4.5M0.9%Unchanged13F ↗
33TNDM
Tandem Diabetes Care, Inc.
267,091$4.4M0.9%Unchanged13F ↗
34HCA
HCA Healthcare, Inc.
10,000$4.3M0.9%New13F ↗
35ASND
Ascendis Pharma A/S
18,305$4.2M0.9%-14.1%13F ↗
36TVTX
Travere Therapeutics, Inc.
68,000$4.0M0.8%-15.0%13F ↗
37MDGL
Madrigal Pharmaceuticals, Inc.
6,500$3.3M0.7%New13F ↗
38CYTK
Cytokinetics, Incorporated
45,000$3.0M0.6%Unchanged13F ↗
39DNLI
Denali Therapeutics Inc.
137,718$2.8M0.6%New13F ↗
40ARDX
Ardelyx, Inc.
686,844$2.3M0.5%Unchanged13F ↗
41VRDN
Viridian Therapeutics, Inc.
84,867$1.7M0.4%New13F ↗

Changes since Q2 2026

7 new, 10 added to, 17 trimmed, 6 exited, 7 unchanged. By estimated dollars.

New positions (7)

New positions
DHR
Danaher Corporation
63,381New$14.0M
UNH
UnitedHealth Group Incorporated
20,000New$7.3M
AZN
AstraZeneca PLC
45,049New$7.3M
HCA
HCA Healthcare, Inc.
10,000New$4.3M
MDGL
Madrigal Pharmaceuticals, Inc.
6,500New$3.3M
DNLI
Denali Therapeutics Inc.
137,718New$2.8M
VRDN
Viridian Therapeutics, Inc.
84,867New$1.7M

Added to (10)

Added to
BSX
Boston Scientific Corporation
308,128+154%$8.2M
PFE
Pfizer, Inc.
1.27M+26.2%$7.5M
IONS
Ionis Pharmaceuticals, Inc.
330,037+74.2%$6.3M
BRKR
Bruker Corporation
217,352+42.7%$4.2M
CVS
CVS Health Corporation
196,574+26.5%$3.5M
GEHC
GE HealthCare Technologies Inc.
256,906+23.6%$3.2M
BIIB
Biogen Inc.
66,646+23.0%$2.8M
MDT
Medtronic plc.
381,245+8.2%$2.5M
LH
Labcorp Holdings Inc.
31,019+19.2%$1.5M
PTCT
PTC Therapeutics, Inc.
112,000+12.0%$777.4K

Trimmed (17)

Trimmed
IQV
IQVIA Holdings, Inc.
42,283-45.8%-$9.6M
IOVA
Iovance Biotherapeutics, Inc.
388,466-59.9%-$8.6M
BMY
Bristol-Myers Squibb Company
612,962-15.6%-$7.1M
AVTR
Avantor, Inc.
606,088-33.1%-$4.5M
MRK
Merck & Company, Inc.
193,044-11.0%-$3.5M
BDX
Becton, Dickinson and Company
75,630-18.8%-$3.1M
QGEN
Qiagen N.V.
231,170-19.6%-$2.5M
INCY
Incyte Corporation
155,100-9.2%-$1.9M
ELV
Elevance Health, Inc.
40,229-9.6%-$1.7M
CNC
Centene Corporation
142,405-12.3%-$1.2M

Exited (6)

Exited
TMO
Thermo Fisher Scientific Inc
33,584Exited-$16.8M
AMGN
Amgen Inc.
26,281Exited-$9.5M
DXCM
DexCom, Inc.
102,122Exited-$6.9M
Crinetics Pharmaceuticals In114,628Exited-$4.3M
OGN
Organon & Co.
270,781Exited-$3.7M
NTLA
Intellia Therapeutics, Inc.
185,177Exited-$3.1M

The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.

Compare two quarters

Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.

Reported value by quarter

Value and number of positions at the end of each quarter.

Loading…

Largest positions in earlier quarters

Pick a quarter to see what the fund's biggest positions were then.

Loading…

Ten largest positions

By value, Q3 2026.

$0$10.0M$20.0M$30.0M$40.0MBMY · Value: $38,248,829BMYPFE · Value: $36,144,366PFEMDT · Value: $32,897,631MDTMRK · Value: $28,051,224MRKINCY · Value: $18,821,385INCYBMRN · Value: $17,597,580BMRNCVS · Value: $16,844,426CVSGEHC · Value: $16,793,945GEHCELV · Value: $15,641,840ELVBIIB · Value: $15,053,998BIIB

Filings

13F filings
Filing
Q3 2026Nov 12, 202613F-HR41$485.0MCurrentSEC ↗
Q2 2026Aug 12, 202613F-HR40$461.0MCurrentSEC ↗
Q1 2026May 7, 202613F-HR42$423.5MCurrentSEC ↗
Q4 2025Feb 12, 202613F-HR36$438.7MCurrentSEC ↗
Q3 2025Oct 31, 202513F-HR41$403.3MCurrentSEC ↗
Q2 2025Jul 31, 202513F-HR38$305.9MCurrentSEC ↗
Q1 2025May 13, 202513F-HR33$312.2MCurrentSEC ↗

Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer